189 related articles for article (PubMed ID: 20352389)
21. Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate.
Phaechamud T; Charoenteeraboon J
AAPS PharmSciTech; 2008; 9(3):829-35. PubMed ID: 18626774
[TBL] [Abstract][Full Text] [Related]
22. In vitro elution of amikacin and vancomycin from impregnated plaster of Paris beads.
Atilla A; Boothe HW; Tollett M; Duran S; Diaz DC; Sofge J; Boothe DM
Vet Surg; 2010 Aug; 39(6):715-21. PubMed ID: 20704692
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber.
Perry AC; Rouse MS; Khaliq Y; Piper KE; Hanssen AD; Osmon DR; Steckelberg JM; Patel R
Clin Orthop Relat Res; 2002 Oct; (403):49-53. PubMed ID: 12360007
[TBL] [Abstract][Full Text] [Related]
24. In vitro elution and antibacterial activity of clindamycin, amikacin, and vancomycin from R-gel polymer.
Thomas LA; Bizikova T; Minihan AC
Vet Surg; 2011 Aug; 40(6):774-80. PubMed ID: 21770984
[TBL] [Abstract][Full Text] [Related]
25. Hydrogel Dressing with a Nano-Formula against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Diabetic Foot Bacteria.
El-Naggar MY; Gohar YM; Sorour MA; Waheeb MG
J Microbiol Biotechnol; 2016 Feb; 26(2):408-20. PubMed ID: 26597531
[TBL] [Abstract][Full Text] [Related]
26. In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin-layer (PRF)-a laboratory evaluation of a modern, autologous wound treatment.
Knafl D; Thalhammer F; Vossen MG
PLoS One; 2017; 12(7):e0181090. PubMed ID: 28686663
[TBL] [Abstract][Full Text] [Related]
27. Ciprofloxacin and Rifampin Dual Antibiotic-Loaded Biopolymer Chitosan Sponge for Bacterial Inhibition.
Wells CM; Beenken KE; Smeltzer MS; Courtney HS; Jennings JA; Haggard WO
Mil Med; 2018 Mar; 183(suppl_1):433-444. PubMed ID: 29635619
[TBL] [Abstract][Full Text] [Related]
28. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
Peng YJ; Kau YC; Wen CW; Liu KS; Liu SJ
J Biomed Mater Res A; 2010 Aug; 94(2):426-32. PubMed ID: 20186737
[TBL] [Abstract][Full Text] [Related]
29. Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections.
Hassan D; Omolo CA; Fasiku VO; Mocktar C; Govender T
Int J Biol Macromol; 2020 Mar; 147():385-398. PubMed ID: 31926237
[TBL] [Abstract][Full Text] [Related]
30. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
Chan E; Zhou S; Srikumar S; Duan W
Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
[TBL] [Abstract][Full Text] [Related]
31. In-vitro model for bacterial growth inhibition of compartmentalized infection treated by an ultra-high concentration of antibiotics.
Topaz M; Athamna A; Ashkenazi I; Shpitz B; Freimann S
PLoS One; 2021; 16(6):e0252724. PubMed ID: 34101731
[TBL] [Abstract][Full Text] [Related]
32. Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control.
Parker AC; Jennings JA; Bumgardner JD; Courtney HS; Lindner E; Haggard WO
J Biomed Mater Res B Appl Biomater; 2013 Jan; 101(1):110-23. PubMed ID: 22997172
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a chitosan-polyethylene glycol paste as a local antibiotic delivery device.
Rhodes CS; Alexander CM; Berretta JM; Courtney HS; Beenken KE; Smeltzer MS; Bumgardner JD; Haggard WO; Jennings JA
World J Orthop; 2017 Feb; 8(2):130-141. PubMed ID: 28251063
[TBL] [Abstract][Full Text] [Related]
34. Release of vancomycin from multilayer coated absorbent gelatin sponges.
Shukla A; Fang JC; Puranam S; Hammond PT
J Control Release; 2012 Jan; 157(1):64-71. PubMed ID: 21939701
[TBL] [Abstract][Full Text] [Related]
35. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Baltch AL; Bassey C; Fanciullo G; Smith RP
J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of chitosan coated metal organic frameworks (MOFs) for increasing vancomycin bactericidal potentials against resistant S. aureus strain.
Ghaffar I; Imran M; Perveen S; Kanwal T; Saifullah S; Bertino MF; Ehrhardt CJ; Yadavalli VK; Shah MR
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110111. PubMed ID: 31546392
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin-loaded chitosan aerogel particles for chronic wound applications.
López-Iglesias C; Barros J; Ardao I; Monteiro FJ; Alvarez-Lorenzo C; Gómez-Amoza JL; García-González CA
Carbohydr Polym; 2019 Jan; 204():223-231. PubMed ID: 30366534
[TBL] [Abstract][Full Text] [Related]
38. Release of vancomycin and teicoplanin from a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides.
Drognitz O; Thorn D; Krüger T; Gatermann SG; Iven H; Bruch HP; Muhl E
Infection; 2006 Feb; 34(1):29-34. PubMed ID: 16501900
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial and Hemostatic Thiol-Modified Chitosan-Immobilized AgNPs Composite Sponges.
Wu Z; Zhou W; Deng W; Xu C; Cai Y; Wang X
ACS Appl Mater Interfaces; 2020 May; 12(18):20307-20320. PubMed ID: 32298570
[TBL] [Abstract][Full Text] [Related]
40. Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
Pawar V; Srivastava R
Int J Pharm; 2019 Sep; 568():118553. PubMed ID: 31344444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
